Falling prescription drug costs are emerging as a key development in the broader push to rein in U.S. health care spending, with new pricing shifts beginning to show up at the pharmacy counter.

Medicare Director Chris Klomp joined FOX Business’ Maria Bartiromo on “Mornings with Maria” to discuss how recent policy changes are starting to impact affordability across the health care system.

TOM BRADY OPENS UP ABOUT HIS HEALTH AMID GLP-1 SURGE: WATER, MOVEMENT AND DISCIPLINE

Klomp pointed to early signs that pricing pressure is easing, particularly for high-demand medications like GLP-1 drugs, which have surged in popularity but have remained out of reach for many patients. He attributed the recent price declines to actions taken by President Donald Trump to lower drug costs through new pricing initiatives.

“If you need a GLP-1, you’re now paying half of what you were paying just a couple of months ago before he announced those deals,” Klomp said.

Klomp framed the pricing changes as part of a broader effort to address affordability challenges that have prevented many Americans from filling prescriptions.

RISING HEALTHCARE COSTS, INSURANCE PREMIUMS NOW WORRY AMERICANS MORE THAN ANY OTHER DOMESTIC ISSUE: POLL

Woman injecting a syringe of medicine into her stomach (David Petrus Ibars/Getty Images / Getty Images)

“That’s solving the problem for a quarter of Americans who can’t pick up a prescription when they get to the pharmacy counter because they can’t afford it right now,” Klomp said.

The price drop reflects a broader effort to align drug costs more closely with international benchmarks while increasing competition in the market. GLP-1 medications, commonly used for diabetes and weight management, have become a focal point in the affordability debate as demand continues to climb.

Klomp suggested the changes extend beyond a single drug class, pointing to similar trends in other treatments where costs have historically been a barrier to access.

“If you want to grow your family, you need to pick up fertility medicine again. You’re paying about half for those drugs, saving you thousands of dollars per cycle of treatment than you were just a couple months ago,” he said.

The shifts come as policymakers look for ways to reduce out-of-pocket costs while maintaining long-term sustainability in federal health care programs.

“[Trump’s] delivering on affordability for every American family to be their healthiest self,” Klomp said.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

PE-backed firm teams up with Royal Fulfillment for centres in New Jersey, Chicago and Los Angeles

Logistics tech specialist fulfilmentcrowd is expanding its US network with new centres in New Jersey, Chicago and Los Angeles.

Chorley-based fulfilmentcrowd has teamed up with American group Royal Fulfillment on the centres designed to “support high-volume eCommerce and B2B distribution across the United States” and to offer coast-to-coast coverage for brands serving the US market. They will replace the group’s two previous US sites.

Last year fulfilmentcrowd secured an investment from private equity group Palatine, which said it wanted to help the logistics group continue its growth in the UK, Europe, Australia and the US.

Royal Fulfillment is a family-run operator with more than 18 years of industry experience. Its centres can handle both direct-to-consumer and large-scale retail distribution, and the business has worked with major retailers such as Amazon, Walmart and Sephora.

Fulfilmentcrowd says its expanded US network will give its customers access to a wider range of US shipping services, including through carriers such as USPS, FedEx and DHL

Lee Thompson, CEO at fulfilmentcrowd, said: “The US is a critical growth market for many of our clients. With this three-centre network, we’re aiming to reduce operational friction at scale, giving global brands the ability to operate domestically across the US with speed, flexibility and cost control built in.”

He added: “This is about more than just adding locations. These centres add to a network that already reflects how modern brands operate: omnichannel, fast-moving and customer-first. Now we can support these requirements across the entire United States.”

JPMorgan Chase CEO Jamie Dimon warned that New York City and other cities with high taxes and regulatory burdens run the risk of losing businesses and workers to locales with more hospitable business climates.

Dimon released his annual letter to shareholders on Monday in conjunction with the firm’s 2025 annual report and said that companies need to weigh the benefits of operating in places like New York City against areas with lower taxes on businesses and individuals.

“No matter who you are, you need to deal with reality and the truth. The truth is that while New York City has much going for it, particularly for financial companies (because of extraordinary local talent), it also has the highest city and state corporate taxes and the highest individual income and state taxes,” Dimon wrote.

“People often make this a moral or loyalty issue, but it is not. Companies need to remain competitive in this very tough, fast-moving world. And higher taxes lower returns on capital and less competitiveness by their nature,” he said.

JAMIE DIMON WARNS IRAN WAR COULD DRIVE INFLATION, INTEREST RATES HIGHER

JPMorgan Chase CEO Jamie Dimon said that cities and states have to compete to keep businesses in their jurisdictions. (Alexander Tamargo/Getty Images for America Business Forum)

Dimon said while companies relocating their headquarters or significant aspects of their operations to states with more favorable tax and regulatory regimes may be easier to track, those shifts happen at the employee level as well and can amount to significant moves for the workforce.

“Additionally, individuals vote with their feet – you can already see a fairly large exodus of people and jobs out of some states with high taxes and high expenses (often due to high taxes and regulatory burdens). Sometimes you see companies leaving states, but migration also shows up in shifts of employees out of certain states,” Dimon wrote.

JAMIE DIMON SAYS US MUST ‘FINISH THIS THING’ WITH IRAN TO PROTECT GLOBAL ECONOMY

JPMorgan Chase has expanded its presence in Texas while its headcount has declined in New York City. (Tim Clayton/Corbis via Getty Images)

He explained how that dynamic has played out at JPMorgan, which has expanded its footprint in a low-tax state like Texas and will probably continue to do so.

“For example, while New York City is still our company’s global headquarters, we have shrunk our headcount in the city, from 30,000 a decade ago to 24,000 today, and increased our headcount in Texas, from 26,000 in 2015 to 32,000 today. This trend will likely continue,” Dimon said.

JAMIE DIMON SAYS US HAS ‘BECOME LIKE EUROPE’ ON DEFENSE, AND IT’S HOLDING THE COUNTRY BACK

The JPMorgan CEO said that he has seen an exodus of corporations out of New York City before that was driven in part by the business climate, adding it can pose significant problems for city governments.

“Sometimes this can be a disaster for a city. I am reminded that in the 1970s, nearly half of the 125 Fortune 500 companies based in New York City left,” he wrote. “While mergers accounted for some departures, the price of doing business in New York City accounted for most: cost of taxes, office rents, labor and so on.” 

GET FOX BUSINESS ON THE GO BY CLICKING HERE

“No city – or company or country – has a divine right to success,” Dimon added.